TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma

Overview of attention for article published in Cancer Immunology Research, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 16,738 followers.

Fabulous talk by @wolchokj right now during #AACRtii21! Checkout the group's latest work in this @CIR_AACR paper on #biomarkers of response to #nivolumab and #ipilimumab in patients with advanced #melanoma. https://t.co/VuYeTZJBLR

RT @humanimmunenews: Combined assessment of tumor mutational burden, #inflammatory gene expression signature, and BRAF mutation status may…

RT @humanimmunenews: Combined assessment of tumor mutational burden, #inflammatory gene expression signature, and BRAF mutation status may…

Combined assessment of tumor mutational burden, #inflammatory gene expression signature, and BRAF mutation status may be predictive for response to #immune checkpoint blockade in advanced melanoma. @CIR_AACR: https://t.co/lQlziweBCU https://t.co/MsqcclOsQ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.